Comments: IL HB1721 | 2021-2022 | 102nd General Assembly
Bill Title: Amends the Illinois Food, Drug and Cosmetic Act. Requires a manufacturer of a prescription drug that is sold, offered for sale, or distributed in this State, or placed on a formulary to be eligible for payment, co-payment, or reimbursement in this State, to notify the Department of Public Health of specified information concerning active pharmaceutical ingredients.
Sponsorship: Bipartisan Bill
Status: (Introduced - Dead) 2021-04-23 - Rule 19(a) / Re-referred to Rules Committee [HB1721 Detail]
Text: Latest bill text (Introduced) [HTML]
Sponsorship: Bipartisan Bill
Status: (Introduced - Dead) 2021-04-23 - Rule 19(a) / Re-referred to Rules Committee [HB1721 Detail]
Text: Latest bill text (Introduced) [HTML]
PolitiCorps Conversations
Start PolitiCorps Debate| Title | PolitiCorps | Access | Comments | Views | Last Post |
|---|---|---|---|---|---|
| There are no visible public or private PolitiCorps discussions concerning the 2021 Illinois HB1721 at this time. | |||||
